Blanchet-Réthoré Sandrine, Bourdès Valérie, Mercenier Annick, Haddar Cyrille H, Verhoeven Paul O, Andres Philippe
CUTIS (Clinical Unit for Tests and Imaging of Skin), Evaluation Department, Nestlé Skin Health/Galderma Research and Development, Sophia-Antipolis, France.
Host Microbiome Interaction Group, Gut Ecosystem Department, Institute of Nutritional Science, Nestlé Research Center, Lausanne, Switzerland.
Clin Cosmet Investig Dermatol. 2017 Jul 3;10:249-257. doi: 10.2147/CCID.S135529. eCollection 2017.
dominates the skin microbiota in patients with atopic dermatitis (AD), with bacterial loads correlating with disease severity. The aim of this exploratory study was to investigate the effect of a cosmetic lotion containing heat-treated NCC 533 (HT La1) on colonization in AD patients.
This open-label, multicenter study was performed in AD patients in Germany. First, detection of was performed in all patients using the swab or scrub-wash method of sampling, followed by quantitative culture or quantitative polymerase chain reaction. Repeatability and reproducibility of all method combinations were evaluated to select the best combination of sampling and quantification. Second, a lotion containing HT La1 was applied to lesional skin twice daily for 3 weeks. Scoring using local objective SCORing Atopic Dermatitis (SCORAD), measurement of load, and lesional microbiome analysis were performed before and after the 3-week treatment period.
Thirty-one patients with AD were included in the study. All sampling and quantification methods were found to be robust, reproducible, and repeatable for assessing load. For simplicity, a combination of swab and quantitative polymerase chain reaction was chosen to assess the efficacy of HT La1. Following application of a lotion containing HT La1 to AD lesions for 3 weeks, a reduction in load was observed in patients, which correlated with a decrease in local objective SCORAD. Interestingly, high baseline skin concentrations of were associated with good responses to the lotion.
This study demonstrated that the application of a lotion containing HT La1 to the lesional skin of patients with AD for 3 weeks controlled colonization and was associated with local clinical improvement (SCORAD). These findings support further development of topical treatments containing heat-treated nonreplicating beneficial bacteria for patients with AD.
在特应性皮炎(AD)患者中占主导地位,其细菌载量与疾病严重程度相关。本探索性研究的目的是调查含有热处理的NCC 533(HT La1)的化妆水对AD患者中 定植的影响。
这项开放标签、多中心研究在德国的AD患者中进行。首先,使用拭子或擦洗冲洗采样方法对所有患者进行 的检测,随后进行定量培养或定量聚合酶链反应。评估所有方法组合的重复性和再现性,以选择采样和定量的最佳组合。其次,将含有HT La1的化妆水每天两次涂抹于皮损处,持续3周。在3周治疗期前后进行使用局部特应性皮炎客观评分(SCORAD)进行评分、 载量测量和皮损微生物群分析。
31例AD患者纳入研究。发现所有采样和定量方法在评估 载量方面均稳健、可重复且可再现。为简便起见,选择拭子与定量聚合酶链反应的组合来评估HT La1的疗效。在AD皮损处涂抹含有HT La1的化妆水3周后,观察到患者的载量降低,这与局部客观SCORAD评分的降低相关。有趣的是,较高的基线皮肤 浓度与对化妆水的良好反应相关。
本研究表明,在AD患者皮损处涂抹含有HT La1的化妆水3周可控制 定植,并与局部临床改善(SCORAD)相关。这些发现支持进一步开发含有热处理的非复制性有益细菌的局部治疗方法用于AD患者。